Literature DB >> 23743204

Overexpression of dnIKK in mesenchymal stem cells leads to increased migration and decreased invasion upon TNFα stimulation.

Florian Haasters1, Wolf Christian Prall, Ines Westphal, Wolfgang Böcker, Daniela Padula, Wolf Mutschler, Denitsa Docheva, Matthias Schieker.   

Abstract

IκB kinase 2 (IKK-2) mediates tumor necrosis-factor α (TNFα) induced invasion of human mesenchymal stem cell (hMSC) to sites of tissue injury. Suppressing IKK-2 activity leads to reduced expression of proteolytic enzymes and impaired invasive capacity. In order to further reveal mechanisms of hMSC recruitment, we here aimed to analyse the impact of IKK-2 on two-dimensional migration upon TNFα stimulation in contrast to three-dimensional invasion. An immortalized hMSC line (SCP-1) was transduced with a dominant-negative mutant of IκB kinase 2 (SCP-1 dnIKK). Migration was assessed using a linear-gradient chemotaxis chambers by time-lapse analysis. Invasive capacity through human extracellular matrix was analysed using transwell invasion assays. RT-PCR confirmed increased IKK-2 expression levels in SCP-1 dnIKK cells, while TNFα receptor I and II expression was not altered. Invasion upon TNFα stimulation was significantly reduced by 78% in SCP-1 dnIKK. In contrast, migration was significantly increased, represented by a 60% elevated forward migration index and a 2.1-fold higher mean dislocation of the center of mass towards TNFα. In conclusion, our data confirms the impact of IKK-2 in TNFα dependent hMSC recruitment. Interestingly, reducing IKK-2 function increases two-dimensional migration towards TNFα, while invasive capacity is impaired. These findings contribute to a deeper understanding of MSC's biological properties orchestrating the complex processes of stem cell recruitment and homing.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23743204     DOI: 10.1016/j.bbrc.2013.05.091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  In situ gel-forming system for dual BMP-2 and 17β-estradiol controlled release for bone regeneration in osteoporotic rats.

Authors:  Elisabet Segredo-Morales; Ricardo Reyes; María Rosa Arnau; Araceli Delgado; Carmen Évora
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Interleukin-3 enhances the migration of human mesenchymal stem cells by regulating expression of CXCR4.

Authors:  Amruta Barhanpurkar-Naik; Suhas T Mhaske; Satish T Pote; Kanupriya Singh; Mohan R Wani
Journal:  Stem Cell Res Ther       Date:  2017-07-14       Impact factor: 6.832

Review 3.  Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?

Authors:  Jehan J El-Jawhari; Yasser El-Sherbiny; Dennis McGonagle; Elena Jones
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

Review 4.  Mesenchymal stem cells and their microenvironment.

Authors:  Jiaxi Liu; Jinfang Gao; Zixie Liang; Chong Gao; Qing Niu; Fengping Wu; Liyun Zhang
Journal:  Stem Cell Res Ther       Date:  2022-08-20       Impact factor: 8.079

5.  Association of TNF-α with impaired migration capacity of mesenchymal stem cells in patients with systemic lupus erythematosus.

Authors:  Linyu Geng; Xia Li; Xuebing Feng; Jiyun Zhang; Dandan Wang; Jinyun Chen; Rui Liu; Haifeng Chen; Lingyun Sun
Journal:  J Immunol Res       Date:  2014-11-24       Impact factor: 4.818

Review 6.  Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients.

Authors:  Rui-Juan Cheng; An-Ji Xiong; Yan-Hong Li; Shu-Yue Pan; Qiu-Ping Zhang; Yi Zhao; Yi Liu; Tony N Marion
Journal:  Front Cell Dev Biol       Date:  2019-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.